International
Conference on Traditional Medicine and Ethnobotany

September 23-24, 2019
Pullman Kuala Lumpur Bangsar
Kuala Lumpur, Malaysia

Dr. Yi Zhun Zhu

Biography

Dr.Yi Zhun Zhu is a Chair, Professor of Pharmacology, Physician and dean of School of Pharmacy, Macau University of Science and Technology. Dr. Zhu got his Bachelor of Medicine at Shanghai Jiaotong University in 1989 and M.D. /Ph.D. from Faculty of Medicine, University of Heidelberg, Germany in 1995. He joined as a faculty member of the Department of Pharmacology, National University of Singapore (NUS) in 1998 after Postdoc training at Kiel University and industrial experience at Hoechst Marion Roussel (now Sanofil). Dr. Zhu published more than 180 peer-reviewed papers with more than 6300 citations and edited 6 books for his work. He is an editor-in-chief for Cardiovascular Regenerative Medicine and associate editor for J Alzheimer Diseases, Bioscience Reports academic editor for PLoS One and editorial board member of CNS Neuroscience & Therapeutics, Journal of Pharmacology and Drug Metabolism, Frontiers in Neurotrauma. Dr. Zhu is also editor-in-chief for the national text book of Pharmacology (7th and 8th edition [Chinese version] and 1st edition [English version], People’s Medical Publishing House, Dr. Zhu was awarded ‘National Distinguished Young Scientist from Natural Science Foundation of China (NSFC) in 2008 and Chief Scientist of National Key Research Program (973) and Chief-PI for the National Platform of Drug Discovery in 2009. Dr. Zhu further received National Award for Innovative Research Work of the Returnees in 2009 from the State Council and Magnolia Award from Shanghai Government in 2010.Dr. Zhu was awarded 2011 Cheung Kong Chair Professorship by the Ministry of Education, China. In 2014, Dr. Zhu was awarded ‘Health China’ top 10 figures of the year. His research focuses on drug developments especially for heart and brain. The original research of motherwort (transferred to the enterprise for 150 million RMB) received 2 clinical approvals for CFDA as a new class I drug and started clinical phase II research. In September 2012, the US Science magazine reported that Professor Zhu was the most One of the successful Chinese returnees’ scientists (September 2, 2012, p. 1692). In 2017, the American Chemical Society's news journal C&EN featured Professor Zhu's experience in drug development and praised him as one of the pioneers of innovative drug research in China (April 3, 2017, 27-29).

IMPORTANT

DATES

Abstract Submission Opens:
December 18, 2018 - September 09, 2019

Earlybird Registration:
December 20, 2018 - May 28, 2019

Standard Registration:
May 29, 2019 - September 23, 2019